Eric H. Bjerkholt
2019 - Aimmune Therapeutics
In 2019, Eric H. Bjerkholt earned a total compensation of $2M as Chief Financial Officer at Aimmune Therapeutics, a 3% decrease compared to previous year.
Compensation breakdown
Bonus | $4,190 |
---|---|
Non-Equity Incentive Plan | $179,489 |
Option Awards | $1,113,557 |
Salary | $436,500 |
Stock Awards | $311,325 |
Other | $2,000 |
Total | $2,047,061 |
Bjerkholt received $1.1M in option awards, accounting for 54% of the total pay in 2019.
Bjerkholt also received $4.2K in bonus, $179.5K in non-equity incentive plan, $436.5K in salary, $311.3K in stock awards and $2K in other compensation.
Rankings
In 2019, Eric H. Bjerkholt's compensation ranked 5,814th out of 13,971 executives tracked by ExecPay. In other words, Bjerkholt earned more than 58.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,814 | 58th |
Manufacturing | 2,177 | 62nd |
Chemicals And Allied Products | 783 | 64th |
Drugs | 659 | 65th |
Pharmaceutical Preparations | 485 | 65th |
Bjerkholt's colleagues
We found four more compensation records of executives who worked with Eric H. Bjerkholt at Aimmune Therapeutics in 2019.